20
I.G. Ovchinnikova et al. / Journal of Photochemistry and Photobiology A: Chemistry 351 (2018) 16–28
J = 15.6 Hz, H
b
), 7.86 (1
=
, d.d.d J = 8.2, J = 7.2, J = 1.4 Hz, H-7), 7.76
, d.d.d J = 7.9, J = 7.2, J = 1.0 Hz, H-6),
, d J = 2.7 Hz, H-20), 7.18 (1 , d.d J = 8.7, J = 2.7 Hz, H-18),
, d J = 8.5 Hz, H-13), 7.09 (1 , d J = 2.4 Hz, H-10), 6.93 (1 , d.
d J = 8.5, J = 2.4 Hz, H-14), 6.85 (1 , d J = 8.7 Hz, H-17), 6.83 (1H, d
J = 15.6 Hz, H ), 4.14 (2 , m, ?E=2), 4.07–3.99 (2 , m, ?E=2),
3.82 (2 , m, ?E=2), 3.75 (2 , m, ?E=2), 3.68–3.59 (8 , m,
4*?E=2). 13C NMR (DMSO-d6)
/ppm: 161.40 (C-4), 155.53 (C-16),
152.36 (C-2), 148.83 and 148.73 (C-11, C-12), 147.35 (C-8a), 134.57
(C-7),134.22 (C ),129.91 (C-18),129.72 (C-9),128.82 (C-20),127.07
(C-8), 126.36 (C-5), 126.30 (C-6), 123.48 (C-15), 122.73 (C-19),
122.02 (C ), 121.25 (C-14), 120.49 (C-4a), 117.70 (C-17), 114.26 (C-
8.25 (1H, d J = 15.1 Hz, Hb), 8.02 (1H, d.d J = 7.9, J = 1.0 Hz, H-8), 7.75
(1
7.30 (1
7.11 (1
=
, d J = 8.2 Hz, H-8), 7.52 (1
=
=
=
(1H, d.d.d J = 8.3, J = 6.8 Hz, J = 1.5 Hz, H-6), 7.64 (1H, d J = 7.9 Hz, H-
5), 7.34 (1H, d.d.d J = 7.9 Hz, J = 7.1, J = 0.7, H-7), 7.09 (1H, d J = 8.4 Hz,
H-13), 6.99 (1H, d J = 2.2 Hz, H-10), 6.83 (1H, d.d J = 8.4, J = 2.2 Hz, H-
14), 6.77 (1H, d J = 7.5 Hz, H-20), 6.72 (1H, d.d.d J = 7.9, J = 7.2,
=
=
=
=
a
=
=
J = 1.0 Hz, H-18); 6.48 (1H, d J = 15.1 Hz, H
17); 5.88 (1H, t J = 7.2 Hz, H-19), 4.17 (2
?E=2), 3.81 (2 , m, ?E=2), 3.72 (2 , m, ?E=2), 3.64–3.59 (4
m, 2*?E=2), and 3.55 (8 , m, 4*?E=2).
The quinonoid form E-7d (a solution of E-6d in a 10-fold excess of
the base (Me4NOH /ppm:
5H2O)): 1H NMR (DMSO-d6, 500 MHz)
8.70 (1H, d J = 15.1 Hz, H ), 8.05 (1H, d.d J = 7.8, J = 1.0 Hz, H-8), 7.78
a
); 6.14 (1H, d J = 8.4 Hz, H-
=
=
d
=
=
, m, ?E=2), 4.06 (2 , m,
=
=
=
=,
=
b
ꢃ
d
a
b
10), 113.48 (C-13), 70.39 (?E=2), 70.37 (?E=2), 69.60 (2*?E=2),
68.70 (?E=2), 68.61 (?E=2), 68.55 (?E=2), 68.46 (?E=2).
(E)-2-(5-chloro-2-hydroxystyryl)-3-(2,3,5,6,8,9,11,12,14,15-deca-
hydrobenzo[b][1,4,7,10,13,16]hexaoxacyclooctadecin-18-yl)quinazo-
lin-4(3H)-one (6d). (0.15 g, 57%, m. p. 252–254 ꢂE). Found: C 62.92,
H 5.47, N 4.46%. C32H33ClN2O8 requires C 63.10, H 5.46, N 4.60. m/z
(1H, d.d.d J = 8.3, J = 6.8, J = 1.4 Hz, H-6), 7.67 (1H, d J = 8.0 Hz, H-5),
7.39 (1H, d.d.d J = 7.8, J = 7.1, J = 0.7 Hz, H-7), 7.09 (1H, d J = 8.4 Hz, H-
13), 7.01 (1H, d J = 2.2 Hz, H-10), 6.85 (1H, d.d J = 8.4, J = 2.2 Hz, H-
14), 6.82 (1H, d J = 2.5 Hz, H-20), 6.76 (1H, d.d J = 8.8, J = 2.5 Hz, H-
18), 6.69 (1H, d J = 15.1 Hz, H
a
), 6.24 (1H, d J = 8.8 Hz, H-17), 4.16
, m, ?E=2), 3.80 (2 , m, ?E=2), 3.73
, m, ?E=2), 3.63–3.59 (4 , m, 2*?E=2), 3.55 (8 , m,
(2
(2
=
, m, ?E=2), 4.06 (2
=
=
(ESI) (%) 609.1962 (98) [(M+H)+]. IR (DRA,
808 m (arom.); 847 s, 945 m; 1063 m (ns
Earomꢀꢀ
Ealkꢀꢀ ); 1246 m (nas Earomꢀꢀ ꢀꢀ alk); 1340 s, 1424 s,
1473 m, 1515 s, 1551 s; 1598 s, 1627 m, 1657 br s ( , C N,
); 2863 m and 2918 m ( EaromꢀꢀH);
EalkꢀꢀH); 3078 m (
3340 br s (OH). 1H NMR (DMSO-d6)
/ppm: 10.71 (1H, s, OH), 8.12
(1 , d.d J = 7.4, J = 1.2 Hz, H-5), 7.92–7.84 (2H, m, H , H-7), 7.76 (1
d J = 7.9 Hz, H-8), 7.51 (1 , t, J = 7.4 Hz, H-6), 7.35 (1 , d J = 2.4 Hz, H-
20), 7.17 (1 , d.d J = 8.7, J = 2.4 Hz, H-18), 7.12–7.10 (2H, m, H-10, H-
13), 6.97 (1H, d J = 15.5 Hz, H ), 6.91 (1 , d.d J = 8.5, J = 2.1 Hz, H-14),
6.84 (1 , d J = 8.7 Hz, H-17), 4.18–4.03 (4 , m, 2*?E=2), 3.85 (1
m, ?E=2), 3.76 (2 , m, ?E=), 3.69–3.50 (13 , m, ?E=
6*?E=2). 13C NMR (DMSO-d6)
/ppm: 161.47 (C-4), 155.86 (C-
16), 152.55 (C-2), 148.33 and 148.23 (C-11, C-12), 147.40 (C-8a),
134.86 (C-7), 134.60 (C ), 129.92, 129.82, 129.60 (C-9, C-18, C-20),
127.08 (C-8), 126.40 and 126.29 (C-5, C-6), 123.41, 122.63, 122.54,
120.96 and 120.51 (C , C-4a, C-14, C-15, C-19),117.67 (C-17),113.24
n
, cmꢀ1): 697 s, 772 s,
=
=
=
,
?
ꢀꢀ alk); 1129 m
E
4*?E=2).
(
nas
,
ns
,
?
,
? E
d,
E¼E
¼
2.2.2. Synthesis of (E)-2-(2-hydroxystyryl)quinazolinone-linked
benzo[15(18)]crown-5(6) ether complexes 8b,d with KNO3
E¼
?
d,
d,
d
The reaction mixture of the E-isomers 6b (or 6d) (ꢄ0.08 g) in
CHCl3 (15 mL) with KNO3 (0.5 g) was kept on reflux for 6 h, after
that KNO3 was filtered off. With chloroform being evaporated,
crystals of E-8b and E-8d complexes were obtained by slow
concentration of acetonitrile solution.
=
b
=
=,
=
=
a
=
=
=
=
,
KNO3-(E)-2-(2-hydroxystyryl)-3-(2,3,5,6,8,9,11,12,14,15-decahy-
drobenzo[b][1,4,7,10,13,16]hexa-oxacyclooctadecin-18-yl)-quinazo-
=
=
,
d
lin-4(3H)-one (E-8b). 1H NMR (DMSO-d6)
d
/ppm: 10.24 (1H, s, OH),
, d.d J = 7.9, J = 1.1 Hz, H-5), 8.06 (1H, d J = 15.5 Hz, H ), 7.85
, d.d.d J = 8.4, J = 7.1, J = 1.4 Hz, H-7), 7.76 (1 , d J = 7.9 Hz, H-8),
7.50 (1 , d.d.d J = 8.0, J = 7.1, J = 1.1 Hz, H-6), 7.22 (1 , d.d J = 7.7,
J = 1.3 Hz, H-20), 7.15 (2 , m, H-18, H-13, H-10), 6.96 (1 , d.d J = 8.5,
J = 2.3 Hz, H-14), 6.84 (1 , d J = 8.1 Hz, H-17), 6.77 (1 , t J = 7.8 Hz, H-
19), 6.73 (1H, d J = 15.5 Hz, H ), 4.21 (2 , m, ?E=2), 4.10 (2 , m,
?E=2), 3.84 (2 , m, ?E=2) and 3.74 (2 , m, ?E=2), 3.66 (2 , m,
?E=2), 3.59 (4 , m, 2*?E=2), 3.57 (6 , m, 3*?E=2).
8.11 (1
(1
=
b
b
=
=
=
=
=
a
=
=
and 112.52 (C-10, C-13), 69.80 (?E=2), 69.77 (?E=2), 69.74
(2*?E=2), 69.67 (?E=2), 68.65 (?E=2), 68.65 (?E=2), 68.47
=
a
=
=
=
(
?E=2), 68.13 (?E=2), 68.02 (?E=2).
=
=
=
(E)-2-(2-ethoxystyryl)-3-(2,3,5,6,8,9,11,12-octahydrobenzo[b]
=
[1,4,7,10,13]pentaoxacyclopentadecin-15-yl)quinazolin-4(3H)-one
KNO3-(E)-2-(5-chloro-2-hydroxystyryl)-3-(2,3,5,6,8,9,11,12,14,15-
decahydrobenzo[b][1,4,7,10,13,16]hexaoxacyclooctadecin-18-yl)qui-
(6e) (0.14 g, 58%, m. p. 101–103 ꢂE). Found: C 68.62, H 6.18, N 5.07%.
C32H34N2O7 requires C 68.80, H 6.13, N 5.01. IR (DRA,
n
, cmꢀ1):
nazolin-4(3H)-one (E-8d), 1H NMR (DMSO-d6)
d
/ppm: 10.58 (1H, s,
, d.d J = 7.9, J = 1.1 Hz, H-5), 7.94 (1H, d J = 15.5 Hz, H ),
, d.d.d J = 8.4, J = 6.7, J = 1.4 Hz, H-7), 7.76 (1 , d J = 8.1 Hz, H-
8), 7.51 (1 , d.d.d J = 7.8, J = 7.2, J = 0.7 Hz, H-6), 7.31 (1 , d J = 2.6 Hz,
H-20), 7.18 (1 , d.d J = 8.7, J = 2.6 Hz, H-18), 7.17 (2H, m, H-13, H-10),
6.97 (1 , d.d J = 8.4, J = 2.3 Hz, H-14), 6.85 (1 , d J = 8.7 Hz, H-17),
6.83 (1H, d J = 15.5 Hz, H ), 4.21 (2 , m, ?E=2), 4.11 (2 , m,
?E=2), 3.84 (2 , m, ?E=2), 3.75 (2 , m, ?E=2), 3.65 (2 , m,
?E=2), 3.60–3.57 (4 , m, 2*?E=2), 3.56 (6 , m, 3*?E=2).
698 s, 768 m (arom.); 868 s, 932 m, 982 m; 1049 m
(
nas
ns
,
,
OH), 8.12 (1
7.86 (1
=
b
Earomꢀꢀ
?
?
ꢀꢀ
E
alk); 1132 m
(
nas
,
ns
,
Ealkꢀꢀ
?
); 1244 m
(
=
=
Earomꢀꢀ
ꢀꢀ
E
alk); 1335 m, 1470 m, 1515 and 1546 s; 1597 and
=
=
1625 s (
d
,
E
=
E, C¼N); 1672 s (
d
,
E
¼
?); 2870 and 2929 m (
d
,
=
EalkꢀꢀH); 3077 m (
d
,
EaromꢀꢀH). 1H NMR (DMSO-d6)
d
/ppm: 8.12
), 7.86 (1
=
=
(1
=, d.d J = 7.9, J = 1.4 Hz, H-5), 8.02 (1H, d J = 15.6 Hz, H
b
=
,
a
=
=
=
=
d.d.d J = 8.1, J = 7.1, J = 1.4 Hz, H-7), 7.76 (1
(1 , d.d.d J = 7.9, J = 7.1, J = 1.0 Hz, H-6), 7.36 (1
H-20), 7.31 (1 , d.d.d J = 8.3, J = 7.3, J = 1.4 Hz, H-18), 7.12 (1H, d
J = 8.6 Hz, H-13), 7.09 (1H, d J = 2.3 Hz, H-10), 7.01 (1 , d J = 8.3 Hz,
H-17), 6.96–6.92 (2 , m, H-19, H-14), 6.82 (1H, d J = 15.6 Hz, H ),
4.18–4.10 (2 , m, ?E=2), 4.03 (2 , m, ?E=2), 4.00 (2H, q
J = 7.0 Hz, OCH2CH3), 3.82 (2
?E=2), 3.68–3.60 (8
OCH2CH3). 13C NMR (DMSO-d6)
16), 152.58 (C-2), 149.03(C-11), 148.86 (C-12), 147.41 (C-8a), 135.65
(C ), 134.60 (C-7), 130.98 (C-18), 130.88 (C-20) 129.83 (C-9), 127.10
(C-8), 126.39 (C-5), 126.25 (C-6), 123.20(C-15), 121.43 (C ), 121.14
=
, d J = 8.1 Hz, H-8), 7.51
=
=
=, d.d J = 7.7, J = 1.4 Hz,
=
=
=
=
2.2.3. Synthesis of (Z)-2-(2-hydroxystyryl)quinazolinone-linked
benzo[15(18)]crown-5(6) ethers and their complexes with KNO3
=
a
=
=
A solution of isomer E-6b (or E-6d) and E-8b (or E-8d) (ꢄ5 mg,
0.01 mmol) in DMSO-d6 (or in DMSO-d6 with Et3N (1:1),1 mL) was
placed into a 1-cm path length hermetically sealed quartz cell and
exposed to the light of a DRSh-250mercury discharge lamp
(250 W) using an UFS-6 light filter at the distance of 13 cm with air
cooling. The reaction progress was monitored by NMR. After 4 h of
exposure (for E-6b and E-6d) and 10 h (for E-8b and E-8d) (S-
Fig. 12), the 1H NMR spectra have shown that the solution
contained ꢄ 79% of photoinduced Z-isomer, respectively.
=
, t J = 4.4 Hz, ?E=2), 3.74 (2
=
, m,
=, m, 4*?E=2), 1.14 (3=, t J = 7.0 Hz,
d
/ppm: 161.51 (C-4), 157.44 (C-
b
a
(C-14), 120.66 (C-19), 120.46 (C-4a), 114.14 (C-10), 113.62 (C-13),
112.39 (C-17), 70.62 (?E=2), 70.56 (?E=2), 69.82 (?E=2), 69.81
(
?E=2), 68.81(?E=2), 68.64 (3*?E=2), 63.59 (OCH2CH3), 14.39
(Z)-2-(2-hydroxystyryl)-3-(2,3,5,6,8,9,11,12,14,15-decahydro-
(OCH2CH3).
The quinonoid form E-7b (a solution of E-6b in a 10-fold excess of
the base (Me4NOH /ppm:
5H2O)): 1H NMR (DMSO-d6, 500 MHz)
benzo[b][1,4,7,10,13,16]hexaoxacyclooctadecin-18-yl)- quinazolin-4
(3H)-one(Z-6b), 1H NMR (DMSO-d6)
d
/ppm: 9.78 (1H, s, OH),
ꢃ
d
8.14 (1
=
, d.d J = 7.9, J = 1.2 Hz, H-5), 7.79 (1 , d.d.d J = 7.9, J = 7.2,
=